| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |